EUVIMEDEUVIMED entdecken
Crossref

Constructing a Metal–Organic Frameworks‐Based Long‐Acting Sequential Release System for the Treatment of Alzheimer's Disease

Qi Ding, Yun Zhao, Enpeng Xi, Kangning Liu, Nan Gao iD, Guangshan Zhu iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Qi Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Ch…. Hauptthemen laut MEDLINE: Alzheimer Disease, Metal-Organic Frameworks. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, "111" project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the unclear pathogenesis of Alzheimer's disease (AD) and the lack of a completely cured medication, AD patients need to take medication in order and on time every day all one's life, which is difficult for severe memory impairment patients to strictly follow on time. Traditional AD drug carriers, such as sugar coating and capsules, rely on dissolution or fragmentation to achieve drug release, which lacks the interaction between drug molecules and carriers, thus they cannot achieve sufficient long‐acting and sequential drug release. Herein, Mn‐MOF‐74, which ligand structure is similar to two antioxidants dihydroquercetin (DHQ) and resveratrol (Res) is chosen as the carrier. Due to the differences in adsorption energy between DHQ/MOF and Res/MOF, the release speed of DHQ is much faster than Res. Therefore, Mn‐MOF‐74 loaded with DHQ and Res (DR@MOF) showed sequential drug release and a long‐term antioxidant effect for ≈72 h, with an efficacy time six times longer than that of vitamin E. In 5×FAD transgenic mice, DR@MOF exhibited excellent capacity in maintaining oxidative balance in the brain, ameliorating spatial learning and memory deficits, and showed the potential of an AD agent for long‐acting and sequential treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMetal-Organic FrameworksAnimalsResveratrolAntioxidantsMiceMice, TransgenicQuercetinDelayed-Action PreparationsDrug CarriersDrug LiberationHumans

Stichwörter der Autor:innen

Alzheimer's diseasedihydroquercetinlong‐acting treatmentmultivariate interactionsresveratrol

Substanzen

Metal-Organic FrameworksResveratrolAntioxidantsQuercetinDelayed-Action PreparationstaxifolinDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, 130024, China.

ORCID-Profile: Nan Gao, Guangshan Zhu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • "111" project
  • Fundamental Research Funds for the Central Universities, Excellent Youth Team Program
  • Finance Special Project on Medical and Health Talents of the Finance Department of Jilin Province
  • WBE Liver Fibrosis Foundation
  • Jilin Province Science and Technology Development Plan Project
  • National Basic Research Program of China

Zitieren

APA

Ding, Q., Zhao, Y., Xi, E., Liu, K., Gao, N., & Zhu, G. (2025). Constructing a Metal–Organic Frameworks‐Based Long‐Acting Sequential Release System for the Treatment of Alzheimer's Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402425

Vancouver

Ding Q, Zhao Y, Xi E, Liu K, Gao N, Zhu G. Constructing a Metal–Organic Frameworks‐Based Long‐Acting Sequential Release System for the Treatment of Alzheimer's Disease. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402425

BibTeX
@article{Ding2025,
  author = {Ding, Qi and Zhao, Yun and Xi, Enpeng and Liu, Kangning and Gao, Nan and Zhu, Guangshan},
  title = {Constructing a Metal–Organic Frameworks‐Based Long‐Acting Sequential Release System for the Treatment of Alzheimer's Disease},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402425}
}
Kostenlos starten →